Archive

Cancer Therapy Advisor asked Shaji Kumar, MD, to share his thoughts about where we are now and where

Could a Blood Test Help Clinicians Diagnose Multiple Myeloma Earlier?

By

Randi Hernandez

August 29, 2018

Levels of hemoglobin, combined with ESR, PV, and calcium values, were determined to be the blood parameters with the most diagnostic value in multiple myeloma.

Physicians will speak about tumor evolution and AR-indifferent disease at the 2017 ASCO Genitourinar

Male Reproductive Cancers

Brachytherapy Recommended for Treatment of Penile Cancer

By

Debra Hughes, MS

May 8, 2017

Brachytherapy “is the treatment of choice” for men with penile carcinoma whose cancer has not spread to the corpus cavernosum.

Thyroid Cancer Clinical Trials

Papillary Thyroid Cancer: Radiographic SLNB May Lead to Management Change

By

Jason Hoffman, PharmD, RPh

July 5, 2016

The use of the radioguided sentinel lymph node biopsy (rSLNB) technique may lead to management change in more than 33% of patients with papillary thyroid cancer.

Sarcoma Clinical Trials

Regorafenib May Improve PFS for Patients With Metastatic Sarcoma

By

Jonathan Goodman, MPhil

June 15, 2016

Regorafenib provides a statistically significant benefit for non-liposarcoma patients with pre-treated, metastatic sarcoma.

Vitiligo may be associated with tumor response in patients with metastatic melanoma treated with pem

Melanoma Clinical Trials

T-VEC Plus Ipilimumab for Advanced Melanoma Appears More Beneficial Than Monotherapy

By

Jason Hoffman, PharmD, RPh

June 14, 2016

Talimogene laherparepvec (T-VEC), an oncolytic virus, in conjunction with ipilimumab, an immune checkpoint inhibitor, may be more beneficial than either agent alone for patients with advanced melanoma.